Literature DB >> 1813898

Pharmacokinetics of second generation antidepressants: bupropion.

P J Goodnick1.   

Abstract

Bupropion is a relatively dopamine-specific antidepressant approved for release by the Food and Drug Administration in 1989. Topics included in this review are pharmacokinetics as related to blood levels and clinical response, bupropion's use in the elderly and in the medically impaired, and drug interactions of note.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1813898

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


  9 in total

Review 1.  Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.

Authors:  M J Burke; S H Preskorn
Journal:  Clin Pharmacokinet       Date:  1999-08       Impact factor: 6.447

2.  A case report of seizure induced by bupropion nasal insufflation.

Authors:  Stanley Hill; Harminder Sikand; Jonathan Lee
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 3.  The Black Book of Psychotropic Dosing and Monitoring.

Authors:  Alan F Schatzberg; DeBattista Charles
Journal:  Psychopharmacol Bull       Date:  2018-01-15

Review 4.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

Review 5.  Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations.

Authors:  Catherine C Crone; Geoffrey M Gabriel
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 6.  Therapeutic drug monitoring for the treatment of psychiatric disorders. Clinical use and cost effectiveness.

Authors:  R Eilers
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

Review 7.  Chirality and drugs used in psychiatry: nice to know or need to know?

Authors:  R M Lane; G B Baker
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

Review 8.  The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs.

Authors:  Shanna C Trenaman; Susan K Bowles; Melissa K Andrew; Kerry Goralski
Journal:  Pharmacol Res Perspect       Date:  2021-05

9.  Direct evidence that two cysteines in the dopamine transporter form a disulfide bond.

Authors:  Rong Chen; Hua Wei; Erik R Hill; Lucy Chen; Liying Jiang; Dawn D Han; Howard H Gu
Journal:  Mol Cell Biochem       Date:  2006-11-25       Impact factor: 3.842
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.